Fig. 6: Endometrial cancer recurrence by TLS presence across the endometrial cancer molecular classes. | Nature Communications

Fig. 6: Endometrial cancer recurrence by TLS presence across the endometrial cancer molecular classes.

From: Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

Fig. 6: Endometrial cancer recurrence by TLS presence across the endometrial cancer molecular classes.

Endometrial cancer recurrence-free survival calculated according to Kaplan-Meier’s methodology and tested between patients with and without TLS using a two-sided log rank test (alpha 0.05). a Patients with POLEmut endometrial cancer (N = 47) and MMRd endometrial cancer (N = 127). b Patients with p53abn endometrial cancer (N = 83) and NSMP endometrial cancer (N = 121). TLS Tertiary lymphoid structure; POLEmut Pathogenic polymerase epsilon mutation; MMRd Mismatch repair deficient; p53abn p53 abnormal; NSMP No specific molecular profile.

Back to article page